328 related articles for article (PubMed ID: 11882318)
1. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis.
Hayek T; Kaplan M; Raz A; Keidar S; Coleman R; Aviram M
Atherosclerosis; 2002 Mar; 161(1):65-74. PubMed ID: 11882318
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.
Keidar S; Heinrich R; Kaplan M; Hayek T; Aviram M
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1464-9. PubMed ID: 11557673
[TBL] [Abstract][Full Text] [Related]
3. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis.
Kaplan M; Hayek T; Raz A; Coleman R; Dornfeld L; Vaya J; Aviram M
J Nutr; 2001 Aug; 131(8):2082-9. PubMed ID: 11481398
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase.
Fuhrman B; Volkova N; Aviram M
Atherosclerosis; 2002 Apr; 161(2):307-16. PubMed ID: 11888513
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin.
Keidar S; Attias J; Coleman R; Wirth K; Schölkens B; Hayek T
J Cardiovasc Pharmacol; 2000 Jan; 35(1):64-72. PubMed ID: 10630734
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
Keidar S; Attias J; Heinrich R; Coleman R; Aviram M
Atherosclerosis; 1999 Oct; 146(2):249-57. PubMed ID: 10532681
[TBL] [Abstract][Full Text] [Related]
8. ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression.
Wei S; Zhang L; Bailu Wang ; Zhao Y; Dong Q; Pan C; Li C; He D; Yuan Q; Xu F; Chen Y
Biochem Biophys Res Commun; 2019 Apr; 512(1):41-48. PubMed ID: 30853183
[TBL] [Abstract][Full Text] [Related]
9. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose.
Hayek T; Hussein K; Aviram M; Coleman R; Keidar S; Pavoltzky E; Kaplan M
Atherosclerosis; 2005 Nov; 183(1):25-33. PubMed ID: 16216589
[TBL] [Abstract][Full Text] [Related]
10. Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.
Hsu YW; Hsu FF; Chiang MT; Tsai DL; Li FA; Angata T; Crocker PR; Chau LY
J Biomed Sci; 2021 Jan; 28(1):5. PubMed ID: 33397354
[TBL] [Abstract][Full Text] [Related]
11. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.
Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J
Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
13. Alteration of volume-regulated chloride channel during macrophage-derived foam cell formation in atherosclerosis.
Hong L; Xie ZZ; Du YH; Tang YB; Tao J; Lv XF; Zhou JG; Guan YY
Atherosclerosis; 2011 May; 216(1):59-66. PubMed ID: 21338988
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages.
Okutsu R; Yoshikawa T; Nagasawa M; Hirose Y; Takase H; Mitani K; Okada K; Miyakoda G; Yabuuchi Y
Atherosclerosis; 2009 Jun; 204(2):405-11. PubMed ID: 19108834
[TBL] [Abstract][Full Text] [Related]
15. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway.
Yao S; Tian H; Miao C; Zhang DW; Zhao L; Li Y; Yang N; Jiao P; Sang H; Guo S; Wang Y; Qin S
J Lipid Res; 2015 Apr; 56(4):836-47. PubMed ID: 25635126
[TBL] [Abstract][Full Text] [Related]
16. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
17. Red wine administration to apolipoprotein E-deficient mice reduces their macrophage-derived extracellular matrix atherogenic properties.
Kaplan M; Aviram M
Biol Res; 2004; 37(2):239-45. PubMed ID: 15455653
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway.
Keidar S; Attias J
Biochem Biophys Res Commun; 1997 Oct; 239(1):63-7. PubMed ID: 9345270
[TBL] [Abstract][Full Text] [Related]
19. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice.
Rosenblat M; Coleman R; Aviram M
Atherosclerosis; 2002 Jul; 163(1):17-28. PubMed ID: 12048118
[TBL] [Abstract][Full Text] [Related]
20. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
Kaplan M; Aviram M
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
